Skip to content
Disclosery

EXANE DERIVATIVES: DAR position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on DAR, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 14,456 DAR shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 14,456 shares
    Change vs previous 13F -16,792 shares

    0.5% of the 13F portfolio, value $864,292.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 31,248 shares
    Change vs previous 13F +1,737 shares

    0.71% of the 13F portfolio, value $2,511,559.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 29,511 shares
    Change vs previous 13F +26,129 shares

    0.5% of the 13F portfolio, value $2,044,743.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 3,382 shares
    Change vs previous 13F -656 shares

    0.06% of the 13F portfolio, value $243,157.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 4,038 shares
    Change vs previous 13F +242 shares

    0.06% of the 13F portfolio, value $267,915.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 3,796 shares
    Change vs previous 13F not available

    0.08% of the 13F portfolio, value $279,297.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).